Dorval T - Search Results

1

[Phase I trial of a recombinant human interleukin 2. Results in patients with disseminated solid tumors].

Tursz T, Dorval T, Berthaud P, Jouve M, Avril MF, Garcia-Giralt E, Le Chevalier T, Spielmann M, Sevin D, Palangie T, et al. Tursz T, et al. Among authors: dorval t. Presse Med. 1991 Feb 16;20(6):250-4. Presse Med. 1991. PMID: 1826163 French.

2

Phase II trial of vinorelbine/doxorubicin as first-line therapy of advanced breast cancer.

Spielmann M, Dorval T, Turpin F, Antoine E, Jouve M, Maylevin F, Lacombe D, Rouesse J, Pouillart P, Tursz T, et al. Spielmann M, et al. Among authors: dorval t. J Clin Oncol. 1994 Sep;12(9):1764-70. doi: 10.1200/JCO.1994.12.9.1764. J Clin Oncol. 1994. PMID: 8083698 Clinical Trial.

3

[Treatment of cancers of the ovary. Phase II trial of increase of the dose of cisplatin].

Dorval T, Beuzeboc P, Garcia-Giralt E, Jouve M, Livartowski A, Palangie T, Pouillart P. Dorval T, et al. Presse Med. 1993 Jan 30;22(3):104-8. Presse Med. 1993. PMID: 8493214 Clinical Trial. French.

4

IL-2 phase II trial in metastatic melanoma: analysis of clinical and immunological parameters.

Dorval T, Mathiot C, Chosidow O, Revuz J, Avril MF, Guillaume JC, Tursz T, Brandely M, Pouillart P, Fridman WH. Dorval T, et al. Biotechnol Ther. 1992;3(1-2):63-79. Biotechnol Ther. 1992. PMID: 1305893 Clinical Trial.

5

Phase I trial with recombinant interleukin-2 (rIL-2): immune activation by rIL-2 alone or following pretreatment with recombinant interferon-gamma.

Farace F, Mathiot C, Brandely M, Tursz T, Dorval T, Pouillart P, Triebel F, Hercend T, Fridman WH. Farace F, et al. Among authors: dorval t. Clin Exp Immunol. 1990 Nov;82(2):194-9. doi: 10.1111/j.1365-2249.1990.tb05426.x. Clin Exp Immunol. 1990. PMID: 2122928 Free PMC article.

6

[Encephalopathy caused by an ifosfamide-mesna combination].

Beuzeboc P, Dorval T, Garcia-Giralt E, Jouve M, Livartowski A, Palangie T, Scholl S, Pouillart P. Beuzeboc P, et al. Among authors: dorval t. Presse Med. 1988 Apr 2;17(12):591-2. Presse Med. 1988. PMID: 2967486 French. No abstract available.

7

Clinical phase II trial of recombinant DNA interferon (interferon alpha 2b) in patients with metastatic malignant melanoma.

Dorval T, Palangie T, Jouve M, Garcia-Giralt E, Israel L, Falcoff E, Schwab D, Pouillart P. Dorval T, et al. Cancer. 1986 Jul 15;58(2):215-8. Cancer. 1986. PMID: 3719515

8

Protracted continuous infusion of 5-fluorouracil in combination with doxorubicin, vincristine, and oral cyclophosphamide in advanced breast cancer.

Raymond E, Palangie T, Jouve M, Asselain B, Dieras V, Beuzeboc P, Dorval T, Garcia-Giralt E, Livartowski A, Scholl S, Pouillart P. Raymond E, et al. Among authors: dorval t. Cancer Invest. 1996;14(2):91-7. doi: 10.3109/07357909609018882. Cancer Invest. 1996. PMID: 8597907 Clinical Trial.

9

First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancer.

Garcia-Giralt E, Beuzeboc P, Deffontaines D, Diéras V, Dorval T, Jouve M, Palangie T, Scholl S, Pouillart P. Garcia-Giralt E, et al. Among authors: dorval t. J Infus Chemother. 1996 Summer;6(3):149-51. J Infus Chemother. 1996. PMID: 9229328 Clinical Trial.

10

Phase II trial of doxorubicin, 5-fluorouracil, etoposide, and cisplatin in advanced or recurrent endometrial carcinoma.

Pierga JY, Diéras V, Beuzeboc P, Dorval T, Palangié T, Jouve M, Scholl SM, Garcia-Giralt E, Pouillart P. Pierga JY, et al. Among authors: dorval t. Gynecol Oncol. 1997 Aug;66(2):246-9. doi: 10.1006/gyno.1997.4749. Gynecol Oncol. 1997. PMID: 9264570 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

147 results

Search Page

Filters